Adicet Bio, Inc. (ACET)
9.59
+0.16
(+1.70%)
USD |
NASDAQ |
Sep 04, 16:00
9.63
+0.04
(+0.42%)
After-Hours: 20:00
Adicet Bio Market Cap : 89.78M for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 89.78M |
| September 03, 2026 | 88.28M |
| September 02, 2026 | 86.69M |
| September 01, 2026 | 86.69M |
| August 31, 2026 | 81.44M |
| August 28, 2026 | 84.81M |
| August 27, 2026 | 84.35M |
| August 26, 2026 | 83.78M |
| August 25, 2026 | 84.25M |
| August 24, 2026 | 83.32M |
| August 21, 2026 | 86.03M |
| August 20, 2026 | 87.81M |
| August 19, 2026 | 88.84M |
| August 18, 2026 | 85.28M |
| August 17, 2026 | 81.82M |
| August 14, 2026 | 78.45M |
| August 13, 2026 | 77.33M |
| August 12, 2026 | 77.33M |
| August 11, 2026 | 77.04M |
| August 10, 2026 | 75.92M |
| August 07, 2026 | 74.70M |
| August 06, 2026 | 74.24M |
| August 05, 2026 | 85.75M |
| August 04, 2026 | 86.22M |
| August 03, 2026 | 86.50M |
| Date | Value |
|---|---|
| July 31, 2026 | 87.44M |
| July 30, 2026 | 86.96M |
| July 29, 2026 | 79.66M |
| July 28, 2026 | 78.70M |
| July 27, 2026 | 77.36M |
| July 24, 2026 | 74.77M |
| July 23, 2026 | 80.81M |
| July 22, 2026 | 82.25M |
| July 21, 2026 | 77.93M |
| July 20, 2026 | 75.73M |
| July 17, 2026 | 77.93M |
| July 16, 2026 | 78.89M |
| July 15, 2026 | 83.31M |
| July 14, 2026 | 84.75M |
| July 13, 2026 | 82.06M |
| July 10, 2026 | 84.75M |
| July 09, 2026 | 85.80M |
| July 08, 2026 | 88.78M |
| July 07, 2026 | 82.54M |
| July 06, 2026 | 87.05M |
| July 02, 2026 | 86.38M |
| July 01, 2026 | 82.73M |
| June 30, 2026 | 82.92M |
| June 29, 2026 | 82.16M |
| June 26, 2026 | 80.33M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.823B |
| Alnylam Pharmaceuticals, Inc. | 35.59B |
| Anika Therapeutics, Inc. | 278.50M |
| Savara, Inc. | 1.103B |
| Vericel Corp. | 2.057B |
Market Cap Related Metrics
| PEG Ratio | -0.2701 |
| Price to Book Value | 0.7473 |
| Price | 9.59 |
| Earnings Yield | -120.3% |
| PEGY Ratio | -0.2701 |